Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2) (vol 77, pg 1143, 2018)

Charles P.; Terrier B.; Perrodeau E.

首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2) (vol 77, pg 1143, 2018)

【24h】

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2) (vol 77, pg 1143, 2018)

机译：单独定制与固定调度Rituximab方案的比较，以维持ANCA相关的血管炎缓解：多期，随机对照，III期试验（Mainritsan2）的结果（Vol 77，PG 1143,2018）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research》 |2019年第9期|共1页
作者
Charles P.; Terrier B.; Perrodeau E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献

1. Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2) (vol 77, pg 1143, 2018) [J] . Charles P., Terrier B., Perrodeau E. Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2019,第9期

机译：单独定制与固定调度Rituximab方案的比较，以维持ANCA相关的血管炎缓解：多期，随机对照，III期试验（Mainritsan2）的结果（Vol 77，PG 1143,2018）
2. Correction: Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial,Low-dose glucocorticoids [J] . BMJ Open . 2018,第1期

机译：校正：小剂量糖皮质激素加利妥昔单抗与高剂量糖皮质激素加利妥昔单抗在ANCA相关性血管炎（LoVAS）中诱导缓解：一项多中心，开放标签，随机对照试验的方案，低剂量糖皮质激素
3. Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial,Correction: Low-dose glucocorticoids [J] . Yuko Kaneko, Kazuhiro Kurasawa, Takao Sugiyama, BMJ Open . 2017,第12期

机译：小剂量糖皮质激素加利妥昔单抗与高剂量糖皮质激素加利妥昔单抗在ANCA相关性血管炎（LoVAS）中诱导缓解的研究：一项多中心，开放标签，随机对照试验的方案，更正：低剂量糖皮质激素
4. Correction: Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre open-label randomised controlled trial [O] . 2018

机译：校正：小剂量糖皮质激素加利妥昔单抗与大剂量糖皮质激素加利妥昔单抗在ANCA相关性血管炎（LoVAS）中诱导缓解：一项多中心开放标签随机对照试验的方案
5. Correction: Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2) [O] . 2019

机译：校正：单独定制与固定时间表Rituximab方案的比较，以维持ANCA相关的血管炎缓解：多期，随机控制，第III期试验的结果（Mainritsan2）

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2) (vol 77, pg 1143, 2018)

著录项

相似文献

相关主题

期刊订阅